HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Beatrice M Girard Selected Research

Cystitis

1/2022Imatinib Mesylate Reduces Voiding Frequency in Female Mice With Acute Cyclophosphamide-Induced Cystitis.
1/2022Imatinib Mesylate Reduces Neurotrophic Factors and pERK and pAKT Expression in Urinary Bladder of Female Mice With Cyclophosphamide-Induced Cystitis.
1/2021The Role of PIEZO1 in Urinary Bladder Function and Dysfunction in a Rodent Model of Cyclophosphamide-Induced Cystitis.
1/2018Expression and Function of Chemokines CXCL9-11 in Micturition Pathways in Cyclophosphamide (CYP)-Induced Cystitis and Somatic Sensitivity in Mice.
8/2016Effects of CYP-Induced Cystitis on Growth Factors and Associated Receptor Expression in Micturition Pathways in Mice with Chronic Overexpression of NGF in Urothelium.
11/2013Expression and function of transforming growth factor-β isoforms and cognate receptors in the rat urinary bladder following cyclophosphamide-induced cystitis.
7/2013Expression and function of CCL2/CCR2 in rat micturition reflexes and somatic sensitivity with urinary bladder inflammation.
11/2012Effects of CYP-induced cystitis on PACAP/VIP and receptor expression in micturition pathways and bladder function in mice with overexpression of NGF in urothelium.
1/2011Increased expression of interleukin-6 family members and receptors in urinary bladder with cyclophosphamide-induced bladder inflammation in female rats.
5/2010Expression and response of acid-sensing ion channels in urinary bladder to cyclophosphamide-induced cystitis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Beatrice M Girard Research Topics

Disease

15Cystitis
01/2022 - 09/2008
12Inflammation (Inflammations)
07/2019 - 09/2008
4Hypersensitivity (Allergy)
06/2016 - 10/2009
4Abnormal Reflex (Hyperreflexia)
11/2010 - 11/2008
2Visceral Pain
07/2019 - 01/2017
1Weight Gain
08/2021
1Herpes Zoster
01/2021
1Pain (Aches)
07/2019
1Interstitial Cystitis (Interstitial Cystitis, Chronic)
07/2019
1Pelvic Pain
01/2017
1Urinary Bladder Diseases (Bladder Diseases)
04/2016
1Tachycardia (Tachyarrhythmias)
08/2013
1Bradycardia
03/2012
1Referred Pain
01/2011
1Ganglion Cysts (Ganglion)
11/2010
1Hyperalgesia
03/2010
1Peripheral Nerve Injuries
09/2007
1Pheochromocytoma
09/2007

Drug/Important Bio-Agent (IBA)

16Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2022 - 09/2008
9Nerve Growth Factor (NGF)IBA
01/2022 - 09/2008
9Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA
07/2019 - 09/2007
5Proteins (Proteins, Gene)FDA Link
08/2016 - 05/2010
4CytokinesIBA
11/2013 - 11/2008
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 09/2008
3Pituitary Adenylate Cyclase-Activating Polypeptide ReceptorsIBA
07/2019 - 11/2008
3ChemokinesIBA
01/2018 - 03/2010
3Messenger RNA (mRNA)IBA
08/2016 - 11/2008
3Neuropeptide Receptors (Neuropeptide Receptor)IBA
06/2016 - 11/2010
3Protein Isoforms (Isoforms)IBA
11/2013 - 09/2008
3Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA
11/2012 - 11/2008
2Imatinib Mesylate (Gleevec)FDA Link
01/2022 - 01/2022
2Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2022 - 08/2016
2Growth Factor ReceptorsIBA
08/2016 - 02/2011
2Type I Pituitary Adenylate Cyclase-Activating Polypeptide ReceptorsIBA
06/2016 - 11/2008
2Adenosine Triphosphate (ATP)IBA
04/2016 - 11/2008
2insect maxadilan proteinIBA
08/2013 - 11/2010
2GalaninIBA
11/2012 - 03/2012
2Peptides (Polypeptides)IBA
11/2008 - 09/2007
1Nerve Growth Factors (Neurotrophins)IBA
01/2022
1CorticosteroneIBA
08/2021
1Claudin-1IBA
01/2021
1claudin 8IBA
01/2021
1CXC ChemokinesIBA
01/2018
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
08/2016
1Ion Channels (Ion Channel)IBA
04/2016
1Nitric Oxide (Nitrogen Monoxide)FDA Link
04/2016
1Transforming Growth Factors (Transforming Growth Factor)IBA
11/2013
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
07/2013
1diamidino compound 253-50IBA
07/2013
1CCR2 ReceptorsIBA
07/2013
1Antineoplastic Agents (Antineoplastics)IBA
11/2012
1Substance PIBA
11/2012
1Adrenergic Agents (Adrenergic Drugs)IBA
03/2012
1Carbachol (Carbastat)FDA Link
03/2012
1calphostin complexIBA
03/2012
1Neuropeptide YIBA
03/2012
1Metoprolol (Toprol-XL)FDA LinkGeneric
03/2012
1Acetylcholine (Acetylcholine Chloride)FDA Link
03/2012
1Protein Kinase CIBA
03/2012
1N- (2- (4- bromocinnamylamino)ethyl)- 5- isoquinolinesulfonamide (h89)IBA
03/2012
1BIIE 0246IBA
03/2012
1M40 (M 40)IBA
03/2012
1Galanin Receptors (Galanin Receptor)IBA
03/2012
1Interleukin-6 (Interleukin 6)IBA
01/2011
1Phosphotransferases (Kinase)IBA
01/2011
1Acid Sensing Ion ChannelsIBA
05/2010
1alpha- cyano- (3,4- dihydroxy)- N- benzylcinnamideIBA
10/2009
1Adenylyl Cyclases (Adenylyl Cyclase)IBA
11/2008
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
09/2008
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
09/2008